Posted by Michael Wonder on 09 Sep 2020
Another appraisal terminated by NICE
9 September 2020 - That makes it 9 terminated appraisals so this calendar year.
NICE is unable to make a recommendation on the dupilumab (Dupixent) on the NHS for the treatment of patients with chronic rhinosinusitis with nasal polyps because Sanofi did not provide an evidence submission.
NICE will of course review this decision if Sanofi decides to make a submission.
